Together We Rise

The Intelligence of Personalised Health
Genelle is the definitive pioneer in predictive genomics, representing the culmination of a 20-year journey. As a sophisticated multi-omics health intelligent platform, it transcends traditional DNA models by integrating blood biomarkers, microbiome data, epigenomics, and pharmacogenomics. Uniquely in the biotech industry, Genelle remains 100% privately owned and personally funded by Abboud Barakat, operating entirely debt-free, which is a rare testament to the founder’s commitment to the mission.

Powering the experience are proprietary AI algorithms designed to identify key genetic and metabolic markers. These insights inform bespoke supplement formulas with a precision of one in thirty million, alongside tailored fitness and nutrition plans. This creates a scalable wellness protocol that targets the root of individual health issues through state-of-the-art automation.
Genelle replaces generic advice with an evolving biological partnership that is geographically spread across diverse global populations. Operating as a multilingual platform, it draws on data points from Asia to the Middle East, Europe, and the US. Daily habits now sync with a precise biological profile to optimise health and extend life, offering a grounded path to healthy aging.
